• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Gepotidacin
    |
    Weekly News Recap #Phispers Gepotidacin
    FDA okays GSK’s Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma’s India facility

    FDA okays GSK’s Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma’s India facility

    As the year draws to a close, the US Food and Drug Administration (FDA) appears busy approving drugs at a fast pace. This week...

    Impressions : 1488

    J&J plans US$ 55 bn investment in US to avoid Trump’s tariffs; Astra to invest US$ 2.5 bn in Chinese R&D centre

    J&J plans US$ 55 bn investment in US to avoid Trump’s tariffs; Astra to invest US$ 2.5 bn in Chinese R&D centre

    This week’s Phispers brings you lots of news from China. AstraZeneca is investing US$ 2.5 billion in a new Beijing resear...

    Impressions : 1067

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.